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organ motion during tangential breast treatments on 
TomoTherapy. Further studies into these breast treatment 
exit detector fluences are necessary for this method’s 
verification and future development of method robustness. 
The future applications for this method include better 
dosimetric understanding of tangential breast treatments as 
well as possible dynamic delivery compensation for organ 
motions to reduce the patient’s lung and heart dose. 
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Purpose or Objective: Stereotactic Body Radiotherapy is 
increasingly used for early stage Non Small Lung Cancer 
(NSCLC) or oligometastatic disease. For patients with two 
adjacent homolateral tumours, high quality treatment plans 
can be designed to simultaneously treat both tumors with a 
single isocentre. The accuracy of treatment delivery is then 
potentially compromised. A compromise needs to be made 
for differential motion of the two tumors. The aim of this 
study was to quantify inter- and intra-fractional differential 
motion of adjacent tumours eligible for SBRT with a single 
isocentre. 
 
Material and Methods: Patients treated with SBRT for lung 
tumours since 2014 were retrospectively selected from our 
database. Patients were included if they presented with 2 
adjacent homolateral tumours with a distance between the 2 
lesions of ≤5cm (Figure 1). Prior to each treatment session 
patients received a CBCT (CBCTprecor) for tumour alignment. 
Both GTVs in the CBCTprecor were local-rigidly registered to 
the planning CT scan (pCT) using two separate shaped regions 
of interest. These registration results were then subtracted 
to give the differential motion. The post treatment CBCT 
(CBCTpostRT) and post correction CBCT (CBCTpostcor) were 
similarly used to quantify the difference in intra-fraction 
motion (IFM) between the two lesions. Subsequently the 
group mean (GM), systematic (Ʃ) and random (σ) position 
variabilities were calculated for Left/Right (LR), 
Cranial/Caudal (CC) and Anterior/Posterior (AP) directions.  
 
 
Results: Nine patients were included in this analysis, 7 male 
2 female, median age was 63 years. The median distance 
between the tumours was 2.7 cm (range 1.2-4.7cm) All 
tumours were peripherally located, with a median Gross 
Tumour Volume (GTV) of 1.95cc (range 0.2-38.2cc) and 
median tumour amplitude, derived from the 4D pCT of 
0.2,0.4 and 0.4 cm in LR, CC and AP directions respectively. 
The inter-fraction differential tumour motion in terms of GM, 
Ʃ and σ is shown in Table 1. Systematic displacements in CC 
and AP were somewhat larger than the random 
displacements. In 5 patients the tumours moved on average 
towards each other, in the remaining 4 patients the tumours 
moved further apart. Differential IFM (table 1) was typically 
somewhat smaller than inter-fraction motion. Inter-fraction 
motion did not significantly correlate with the inter tumor 
distance for the systematic component but was highly 




Conclusion: Differential motion of 1-3 mm (systematic and 
random variation) was observed in this small retrospective 
study between adjacent lung tumours eligible for single 
isocentre SBRT. However, as a compromise can be made for 
tumour alignment, the values reported in this study should be 
divided by two when calculating margins. 
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Purpose or Objective: To evaluate and to compare the intra-
fraction movements, during Stereotactic Body Radiation 
Therapy (SBRT), obtained with two different methods: Cone 
Beam CT (CBCT) and an infrared Optical Tracking System 
(OTS). 
 
Material and Methods: 10 patients (pts) with lung lesions 
(primary tumour or metastasis) were irradiated with a total 
dose ranging from 36 to 42 Gy in 3 fractions using one or two 
6 MV photons volumetric-modulated arcs by a Varian Clinac 
linear accelerator. Pts were positioned with the arms raised 
on a breast setup system (PosiboardTM, Civco) with a vacuum 
customized cushion. The OTS SMART-DX (BTS Bioengineering, 
Milano, Italy) was used to record the 3D coordinates of 
multiple passive markers (6-8) placed on the patient's 
thoraco-abdominal surface. Ungated CT images was acquired 
for treatment planning (TP). 4DCT images were used for 
clinical target volume (CTV) delineation and a 5mm isotropic 
planning target volume (PTV) was generated. Before the daily 
treatment a CBCT was acquired and registered to the 
planning CT to obtain and apply the setup corrections (only 
translations allowed). After the irradiation a second CBCT 
was performed and rigidly registered to the first CBCT with a 
mutual information algorithm focusing on the CTV region. A 
rigid transformation was also estimated from surface markers 
coordinates acquired by the OTS just before the two CBCT 
scans. Setup corrections were subtracted from the 
rototranslation parameters obtained from both CBCT and 
OTS, in order to evaluate intra-fraction patient 
reproducibility. The results for both CBCT and OTS methods 
were evaluated and compared regardless of rotations 
coordinates always found to be less than 1 degree. 
 
Results: In 39 analyzed fractions the mean absolute values of 
translational displacements obtained with the CBCT method 
was 0.6±0.9 mm in the latero-lateral (LL) direction, 0.7±1.0 
mm in the antero-posterior (AP) direction and 1.0±1.0 mm in 
the cranio-caudal (CC) direction. The same analysis achieved 
in 26 fractions with surface markers, revealed absolute 
displacements of 1.1±1.1 mm in LL, 1.5±0.9 mm in AP and 
1.7±1.7 mm in CC direction. Comparing the shifts obtained 
with the two systems in the same sessions, the resulting 
mean difference was 1.1±1.2 mm in LL, 1.8±1.3 mm in AP 
and 1.7±1.6 mm in CC.  
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Conclusion: The differences between the intra-fraction 
patient displacements observed through CTV overlapping 
using CBCTs and through the surface markers registration 
seem to be clinically acceptable for the PTV considered. The 
relatively greater spread using markers is probably due to the 
larger portion of patient’s surface covered by the OTS 
compared to the CTV region. Considering the adopted PTV 
margin, the non-invasive OTS could be therefore used to 
monitor the intra-fraction movements as alternative to a post 
treatment CBCT, possibly using markers positioned in a 
restricted area around the target. 
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Purpose or Objective: SBRT is now an accepted treatment 
for inoperable pts with stage I lung cancer and 
oligometastatic disease.Particularly for SBRT, tumor motion 
must be taken into consideration due to high dose per 
fraction. It is unclear which system provides the best 
accuracy for target localization.The aim of this study is to 
evaluate the role of lung optimization treatment(LOT) 
simulation for the best tumor tracking using Cyberknife SBRT. 
 
Material and Methods: From September 2014 to July 2015 we 
evaluated 143 consecutive pts referred to our department for 
tracking modality.For everyone a CT scan was performed in 
expiratory and inspiratory phase.During the simulation the 
position and setup were the same as those during the 
treatment. The real-time images were compared to the DRRs 
where the target was evidenced.Cyberknife includes a small 
6 MV LINAC mounted on a robotic arm,two diagnostic X-ray 
sources (installed in the ceiling of the treatment room) 
attached to digital image collectors, placed orthogonally to 
the patient to provide real-time treatment guidance, and a 
table remotely controlled that can move around different 
axes and adjust the patient position. 
 
Results: According to the accuracy of the LOT system in 
target identification we observed these solutions:we treated 
102 pts (71%) with Xsight lung technique, 80 pts in 2-view 
modality in which the target was recognized and tracked 
from both X-Ray cameras and 22 pts in 1-view modality,in 
which only one camera was used. XSight lung along with 
Synchrony Respiratory Tracking can automatically track and 
adjust the beam to tumor motion, using the lesion as a 
fiducial.The GTVs were expanded by 3 mm in all directions to 
create the CTVs .We used different margins for PTVs. In the 
2-view modality the CTV on expiratory CT was expanded by 
2mm in all directions,while for 1 view modality two different 
CTVs were generated on both CT scan to include the entire 
inhale-to-exhale tumor motion, and added together to create 
an ITV expanded by 2 mm in the direction followed by the X-
Ray camera and 3mm in the other direction.For the other 40 
lesions (29%),when the tumor cannot be clearly identified by 
either of the two cameras,fiducials have been necessary. 
 
Conclusion: LOT simulation system is a very effective, useful 
and non-invasive technique. Dramatically reducing PTV 
margins and consequently the risk of potential toxicities 
related to the high doses, LOT simulation system and Xsight 
lung are considered the best choice in the management of 
lung lesions in our clinical practice. 
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Purpose or Objective: We report the preliminary clinical 
results organ motion mitigation strategies in the treatment of 
moving target with active scanned carbon ion beams. 
 
Material and Methods: Since September 2014 26 patients 
with tumors located in the upper abdomen and chest were 
treated with active scanned carbon ion beams. Patients were 
affected by pancreatic adenocarcinoma, HCC, biliary tract 
cancers and sarcoma of the spine retroperitoneum and heart. 
Tight thermoplastic mask was selected as the optimal 
abdominal compression device. 4D CT scan with retrospective 
reconstruction, with phase signal obtained with Anzai system 
(Anzai Medical CO., LTD), was employed for planning. 
Automatic assignment of raw data to respiratory phases was 
checked and, if necessary, modified by the medical physicist. 
Planning was performed using end expiration phase. Planning 
CT scans were visually checked for motion artifacts. 
Contouring was performed on end expiration phase and on 
the adjacent 30% expiration and 30% inspiration phases. 
Beam entrance was selected in order to avoid the bowel in 
the entrance channel. The lung diaphragm interface was 
contoured in the different respiratory phases and beam 
angles were chosen to avoid passing tangential to the lung 
diaphragm ITV. IMPT was used for plan optimization. Plans 
were recalculated in adjacent phases and if DVHs were 
degraded in an unacceptable way they were modified 
iteratively. Weekly verification 4D CT scans were performed 
and, if needed, a new plan was re-optimized adaptively. Set 
up was verified with gated orthogonal X rays and non-gated 
cone beam CT in treatment room. Threshold for gate-on 
signal was initially set at 10% pressure signal dynamic and 
qualitatively adjusted in an asymmetric way according to 
results of plan recalculation in 30% expiration and inspiration. 
Gating signal was fed to the accelerator to enable beam 
delivery. Each slice was re-scanned 5 times to smear out 
possible interplay effects. Acute and early toxicity was 
scored according to CTCAE 4.0 scale. 
 
Results: GTV and diaphragm excursion between end 
expiration and adjacent 30% phases was reduced to less than 
5 mm. GTV (D95%) and critical OARs (D1%) DVH in 30% 
inspiration and expiration phases showed on average minimal 
(less than 1%) differences as compared to planning end 
expiration plan. Toxicity was minimal with no G3 event. G2 
toxicity was observed in 15% of the patient during treatment 
and in 10% of the patients at 3 months. Median follow up was 
rather short (3 months) nevertheless in 23 patients the dose 
limiting OAR was either stomach or small bowel or esophagus 
, therefore early toxicity data are informative. 
 
Conclusion: Active scanning with carbon ion beams for the 
treatment of moving target using abdominal compression, 4D 
simulation, robust planning, gating and rescanning is feasible 
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